Skip to main content
. 2020 Oct 22;143(2):195–205. doi: 10.1111/ane.13353

TABLE 2.

Patient data and sample 1—GOSE

Unfavourable GOSE 1–4 (n = 17) Favourable GOSE 5–8 (n = 39) p
Sex (female) 14 (82) 28 (72) 0.51
Age (years) 58 (54–64) 56 (48–64) 0.28
GCS 11 (7–13) 14 (13–15) 0.01
Modified Fischer Grade 0–2 0 (0) 4 (10) 0.02
Modified Fischer Grade 3–4 17 (100) 35 (90) 0.02
IL‐1Ra 369 (187–524) 155 (87–253) 0.007
IL‐6 3.30 (0.45–6.93) 0.45 (0.06–2.92) 0.01
TNF–α 23.2 (18.2–29.5) 18.2 (15.1–20.9) 0.02
ICAM−1 178082 (144650–235454) 138668 (87755–190669) 0.05
CRP 49 (15–73) 7 (3–20) 0.01
WCC (1/0) a 12.7 (10.4–16.0) 11.2 (8.9–14.1) 0.23
Platelets (1/0) a 220 (180–252) 251 (199–297) 0.09
Temperature (1/0) a 38.2 (37.6–38.7) 37.9 (37.4–38.2) 0.14

Number (per cent) or median with interquartile ranges. IL‐1Ra, IL‐6, TNF‐α, ICAM‐1 concentrations in picogram/L, CRP in mg/L, WCC and platelets count 109/L, temperature in degrees Celsius.

Two patients were lost to follow‐up, making the total patients with scored GOSE n = 56.

Abbreviations: CRP, C‐reactive protein; ICAM, intracellular adhesion molecule; IL‐1Ra, interleukin‐1 receptor antagonist; IL‐6, interleukin 6, TNF‐α, tumour necrosis factor alpha; WCC, white cell count.

a

Number of missing in the two groups, respectively.